Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

693
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
693
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.3K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
What is Natural Selection?01:32

What is Natural Selection?

129.8K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.8K
Antibiotic Selection00:57

Antibiotic Selection

60.2K
Overview
60.2K
Types of Selection01:46

Types of Selection

45.3K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
45.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time Models.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Unlocking Wafer-Scale 3D Photonic Systems With Ion-Beam-Induced Origami.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Implementation of the Korea Disease Control and Prevention Agency Infectious Disease ALERT: Timely Information Sharing to Strengthen Frontline Healthcare Response.

Public health weekly report·2026
Same author

Biosynthesis of 6-thioguanine: characterizing two intermediates involved in its thioamide formation reaction.

ACS catalysis·2026
Same author

Sero-Epidemiologic Study of Respiratory Syncytial Virus Infection in Korea.

Journal of Korean medical science·2026
Same author

The melon gene CmVTE7 coordinates vitamin E accumulation and heat stress tolerance.

Plant physiology and biochemistry : PPB·2026

関連する実験動画

Updated: Feb 13, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.5K

抗腫瘍活性を持つ強力で選択的なIL-4阻害剤

Raavi, Imron Chaudhry, Daniel F Sheehy

    bioRxiv : the preprint server for biology
    |February 12, 2026
    PubMed
    まとめ

    インタールイウキン-4 (IL-4) を標的とする小分子阻害剤は,免疫媒介疾患の治療に有望であることが示されています. 最適化されたアナログは強力で選択的なIL-4阻害を示し,前臨床モデルでは著しい腫瘍抑制と生存率の改善につながった.

    科学分野:

    • 免疫学 免疫学とは
    • 薬用化学 薬用化学について
    • 薬理学 薬理学とは

    背景:

    • インタールイウキン-4 (IL-4) は,免疫反応を調節する重要なサイトカインであり,がんや自己免疫性などの疾患に起因するシグナル伝達が制御不能である.
    • 抗IL-4受容体アルファ (IL-4Rα) 抗体ドゥピルマブは,IL-4シグナリングを治療標的として強調しています.
    • 以前のNico-52の発見は,溶性IL-4の第1級小分子阻害剤である.

    研究 の 目的:

    • 強化された効能と選択性のために,Nico-52の構造-活性関係 (SAR) を決定する.
    • 小分子IL-4阻害のin vivo抗腫瘍の可能性を評価する.
    • IL-4媒介性疾患における小分子サイトカイン阻害剤の治療的有望性を評価する.

    主な方法:

    • ニコ-52基板の構造-活性関係研究で,p-フッロフェニル基の改変に焦点を当てました.
    • 熱シフトアッセイとHEK Blue IL-4/IL-13レポーターアッセイで,結合選択性と抑制効力を評価する.
    • シンジェニックマウリンの腫瘍モデルにおけるADME/Tプロファイリングとインビボの研究をインビトロで行いました.

    主要な成果:

    • 構造的改変のあるアナログは,サブミクロモラーから2桁のナノモラー強度を達成しました.

    さらに関連する動画

    Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
    09:17

    Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

    Published on: September 16, 2019

    7.3K
    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    24.2K

    関連する実験動画

    Last Updated: Feb 13, 2026

    Isolation and Characterization of Neutrophils with Anti-Tumor Properties
    10:15

    Isolation and Characterization of Neutrophils with Anti-Tumor Properties

    Published on: June 19, 2015

    25.5K
    Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
    09:17

    Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

    Published on: September 16, 2019

    7.3K
    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    24.2K
  • 強力なアナログは,IL-4に選択的に結合し,IL-13よりもIL-4の強力な阻害を示した.
  • 鉛の類型は,タイプIとタイプIIのIL-4受容体シグナル伝達を阻害し,好ましいin vitroADME/T特性を示した.
  • In vivo研究では,腫瘍の有意な阻害,マクロファージの偏差の変化,および鉛の類似品による生存の改善が示されました.

    • 結論:

    • IL-4を標的とする小分子阻害剤は,強力で選択的な阻害のために最適化することができます.
    • 小分子IL-4阻害は,抗腫瘍効果と生存率を改善する可能性を有意に示しています.
    • これらの発見は,IL-4駆動性疾患の治療のための小分子サイトカイン阻害剤の開発をサポートします.